[Carcinogenic properties of hydrazobenzene].
D000230:Adenocarcinoma / Q000139:chemically induced; D000231:Adenocarcinoma, Papillary / Q000139:chemically induced; D000284:Administration, Oral; D000287:Administration, Topical; D000818:Animals; D001555:Benzene Derivatives / Q000494:pharmacology*; D002273:Carcinogens / Q000494:pharmacology*; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced; D005260:Female; D006835:Hydrazones / Q000494:pharmacology*; D007279:Injections, Subcutaneous; D007680:Kidney Neoplasms / Q000139:chemically induced; D008113:Liver Neoplasms / Q000139:chemically induced; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000139:chemically induced; D051381:Rats; D012626:Sebaceous Gland Neoplasms / Q000139:chemically induced; D013997:Time Factors; D014594:Uterine Neoplasms / Q000139:chemically induced
D001555:Benzene Derivatives; D002273:Carcinogens; D006835:Hydrazones
O kantserogennykh svoĭstvakh gidrazobenzola